Blockbuster Oncology Brands Market Size, Revenue, Growth, Trend & Forecast Analysis, 2020 - 2027, By Indication, By Brands, By Country, & By Region

  • Report Id: HCDHR 2450
  • Published Date: August, 2020
  • No of Pages: 150
  • Format: Electronic (PDF)
  • Publisher: DataHorizzon Research
  • Category:

Blockbuster Oncology Brands Market Report Overview

Blockbuster oncology brands market garnered a revenue of USD 30.23 billion in the year 2019 globally. The market has been observed to be growing at a steady growth rate over the last three years, however with the impact of COVID-19 pandemic globally, the business conditions are expected to change. The market size may reduce significantly or increase with a spike depending on how the value chain has been affected in the entire process.

Players that are operational in the market for a longer period of time are anticipated to absorb the sudden changes, losses and increased operational costs better than those who have recently entered the market. The report focuses on numerous factors that are anticipated to impact the market growth directly and indirectly. The report categorically analyses the growth patterns of different segments based on multiple derivation models.

Both the qualitative and quantitative aspects have been covered under the report. The Blockbuster Oncology Brands market report includes market size, drivers, restraints, opportunities and trends that will help you understand the market dynamics in detail. Moreover, the report will include market estimates & forecasts in terms of revenue for the overall market along with the segments mentioned in the study. The report focuses on providing a holistic view of the entire market scenario from multiple unmatched detailed analysis mentioned in the report.

What to expect from the report?

  • Blockbuster Oncology Brands Total Available Market (TAM) Size
  • Blockbuster Oncology Brands Serviceable Available Market (SAM) Size
  • Business Implications of COVID-19 on the Overall Market
  • Market Share/ Revenue Share (%) of Top Market Players in Total Market Size (2019)
  • Market Size & Forecast (2016-2027) At Country & Regional Level, By Segments
  • Overview & Analysis of Key Players Operating in the Market

Key Highlights: 

Parameters

Description

COVID-19

Impact of COVID-19 on overall business scenario

Blockbuster Oncology Brands Market Revenue 2020

Global market revenue in 2020 will be derived taking into various micro & macro level factors; along with COVID-19 pandemic

Competitive Analysis

Company Market Share Analysis, 2019 (%)

Supply Chain Analysis

Analysis pertaining to several participants of supply chain such as raw material suppliers, distributors, & OEMs along with others will be highlighted in the study

Data Source

Primary & Secondary Research, Internal Data Base & Company Annual Reports

Regions Included

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Countries Included

U.S., Canada, U.K., Germany, France, Mexico, Brazil, China, India, Japan, South Korea, UAE, South Africa

Table of Contents
Chapter 1. Research Methodology & Data Sources
1.1. Data Analysis Models
1.2. Research Scope & Assumptions
1.3. List of Primary & Secondary Data Sources
Chapter 2. Executive Summary
Chapter 3. Blockbuster Oncology Brands Market: Industry Analysis
3.1. Market segmentation
3.2. Supply chain analysis
3.3. Porter’s 5 forces analysis
3.4. PEST analysis
3.5. Market Dynamics
3.5.1. Market driver analysis
3.5.2. Market restraint analysis
3.5.3. Market opportunity analysis
3.6. Company Market Share Analysis, 2019
Chapter 4. Blockbuster Oncology Brands Market: Indication Insights
4.1. Global Indication Historic Market Data & Future Forecasts, 2016-2027
4.2. Lymphoma
4.2.1. Historic Market Data & Future Forecasts, 2016-2027
4.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.3. Multiple myeloma
4.3.1. Historic Market Data & Future Forecasts, 2016-2027
4.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.4. Breast cancer
4.4.1. Historic Market Data & Future Forecasts, 2016-2027
4.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.5. Lung Cancer
4.5.1. Historic Market Data & Future Forecasts, 2016-2027
4.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
4.6. Others
4.6.1. Historic Market Data & Future Forecasts, 2016-2027
4.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 5. Blockbuster Oncology Brands Market: Brands Insights
5.1. Global Brands Historic Market Data & Future Forecasts, 2016-2027
5.2. Imbruvica
5.2.1. Historic Market Data & Future Forecasts, 2016-2027
5.2.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.3. Revlimid
5.3.1. Historic Market Data & Future Forecasts, 2016-2027
5.3.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.4. Zejula
5.4.1. Historic Market Data & Future Forecasts, 2016-2027
5.4.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.5. Darzalex
5.5.1. Historic Market Data & Future Forecasts, 2016-2027
5.5.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.6. Tagrisso
5.6.1. Historic Market Data & Future Forecasts, 2016-2027
5.6.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.7. Gazyva
5.7.1. Historic Market Data & Future Forecasts, 2016-2027
5.7.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.8. Tecentriq
5.8.1. Historic Market Data & Future Forecasts, 2016-2027
5.8.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.9. Ibrance
5.9.1. Historic Market Data & Future Forecasts, 2016-2027
5.9.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.10. Perjeta
5.10.1. Historic Market Data & Future Forecasts, 2016-2027
5.10.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.11. Keytruda
5.11.1. Historic Market Data & Future Forecasts, 2016-2027
5.11.2. Historic Market Data & Future Forecasts by Region, 2016-2027
5.12. Opdivo
5.12.1. Historic Market Data & Future Forecasts, 2016-2027
5.12.2. Historic Market Data & Future Forecasts by Region, 2016-2027
Chapter 6. Blockbuster Oncology Brands Market: Regional Insights
6.1. Global Blockbuster Oncology Brands Market Data & Future Forecasts, By Region 2016-2027
6.2. North America
6.2.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.2.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.2.4. U.S.
6.2.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.2.4.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.2.5. Canada
6.2.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.2.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.2.5.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.3. Europe
6.3.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.3.4. U.K.
6.3.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.4.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.3.5. Germany
6.3.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.5.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.3.6. France
6.3.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.3.6.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.3.6.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.4. Asia Pacific
6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.4.4. China
6.4.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.4.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.4.5. India
6.4.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.5.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.4.6. Japan
6.4.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.6.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.6.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.4.7. South Korea
6.4.7.1. Historic Market Data & Future Forecasts, 2016-2027
6.4.7.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.4.7.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.5. Latin America
6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.5.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.5.4. Brazil
6.5.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.5.4.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.5.5. Mexico
6.5.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.5.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.5.5.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.6. Middle East & Africa
6.6.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.6.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.6.4. UAE
6.6.4.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.4.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.6.4.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
6.6.5. South Africa
6.6.5.1. Historic Market Data & Future Forecasts, 2016-2027
6.6.5.2. Historic Market Data & Future Forecasts, By Indication, 2016-2027
6.6.5.3. Historic Market Data & Future Forecasts, By Brands, 2016-2027
Chapter 7. Company Profiles
7.1. Tesaro
7.1.1. Company Description
7.1.2. Financial Highlights
7.1.3. Product Portfolio
7.1.4. Strategic Initiatives
7.2. AstraZeneca
7.2.1. Company Description
7.2.2. Financial Highlights
7.2.3. Product Portfolio
7.2.4. Strategic Initiatives
7.3. Pfizer
7.3.1. Company Description
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. Strategic Initiatives
7.4. Roche
7.4.1. Company Description
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. Strategic Initiatives
7.5. Merck & Co.
7.5.1. Company Description
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. Strategic Initiatives
7.6. Bristol Myers Squibb
7.6.1. Company Description
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. Strategic Initiatives
7.7. xw
7.7.1. Company Description
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. Strategic Initiatives
7.8. xn
7.8.1. Company Description
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. Strategic Initiatives
7.9. xo
7.9.1. Company Description
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. Strategic Initiatives
7.10. xh
7.10.1. Company Description
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. Strategic Initiatives  
List of Tables
Table 1 Blockbuster Oncology Brands Market Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 2 Blockbuster Oncology Brands Market Data & Future Forecasts, By Region, 2016-2027 (USD Billion)
Table 3 Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 4 Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 5 Lymphoma Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 6 Multiple myeloma Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 7 Breast cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 8 Lung Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 9 Others Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 10 Imbruvica Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 11 Revlimid Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 12 Zejula Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 13 Darzalex Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 14 Tagrisso Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 15 Gazvya myeloma Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 16 Tecentriq cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 17 Ibrance Cancer Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 18 Perjeta Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 19 Keytruda Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 20 Opdivo Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 21 North America Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 22 North America Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 23 North America Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 24 U.S. Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 25 U.S. Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 26 U.S. Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 27 Canada Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 28 Canada Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 29 Canada Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 30 Europe Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 31 Europe Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 32 Europe Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 33 U.K. Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 34 U.K Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 35 U.K Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 36 Germany Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 37 Germany Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 38 Germany Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 39 France Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 40 France Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 41 France Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 42 Asia Pacific Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 43 Asia Pacific Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 44 Asia Pacific Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 45 China Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 46 China Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 47 China Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 48 India Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 49 India Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 50 India Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 51 Japan Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 52 Japan Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 53 Japan Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 54 South Korea Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 55 South Korea Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 56 South Korea Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 57 Latin America Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 58 Latin America Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 59 Latin America Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 60 Brazil Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 61 Brazil Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 62 Brazil Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 63 Mexico Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 64 Mexico Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 65 Mexico Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 66 Middle East & Africa Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 67 Middle East & Africa Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 68 Middle East & Africa Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 69 UAE Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 70 UAE Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 71 UAE Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)
Table 72 South Africa Blockbuster Oncology Brands Market Data & Future Forecasts, 2016-2027 (USD Billion)
Table 73 South Africa Blockbuster Oncology Brands Market Data & Future Forecasts, By Indication, 2016-2027 (USD Billion)
Table 74 South Africa Blockbuster Oncology Brands Market Data & Future Forecasts, By Brands, 2016-2027 (USD Billion)

List of Figures
Fig.1 Data Analysis Model
Fig.2 Blockbuster Oncology Brands Market, by 2016-2027 (USD Billion)
Fig.3 Blockbuster Oncology Brands Market Segmentation
Fig.4 Supply chain analysis
Fig.5 Blockbuster Oncology Brands Market Driver Anlaysis
Fig.6 Blockbuster Oncology Brands Market Restraint Analysis
Fig.7 Blockbuster Oncology Brands Market Opportunity Analysis
Fig.8 Porters 5 Forces Model
Fig.9 PEST Analysis- Blockbuster Oncology Brands Market
Fig.10 Company Market Share Analysis, 2019

Blockbuster Oncology Brands Market Segmentation:

Blockbuster Oncology Brands Market, By Indication (2016-2027)

  • Lymphoma
  • Multiple myeloma
  • Breast cancer
  • Lung Cancer
  • Others

Blockbuster Oncology Brands Market, By Brands (2016-2027)

  • Imbruvica
  • Revlimid
  • Zejula
  • Darzalex
  • Tagrisso
  • Gazyva
  • Tecentriq
  • Ibrance
  • Perjeta
  • Keytruda
  • Opdivo

Blockbuster Oncology Brands Market, By Region (2016-2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • South Africa

Major Players Operating in the Blockbuster Oncology Brands Market:

  • Tesaro
  • AstraZeneca
  • Pfizer
  • Roche
  • Merck & Co.
  • Bristol Myers Squibb

Choose License Type

Single user
$3,960
Multi User
$4,950
Enterprise User
$5,940
Clear

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.